Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "avtor" (Mirjana Rajer) .

1 - 10 / 23
Na začetekNa prejšnjo stran123Na naslednjo stranNa konec
1.
Malignant spinal cord compression
Mirjana Rajer, Viljem Kovač, 2008, pregledni znanstveni članek

Povzetek: Malignant spinal cord compression (MSCC) is a common and debilitating neurological complication of cancer. Because of the rapid progression of the neurological dysfunction, it is considered a medical emergency that demands a prompt diagnosis and treatment. Almost all of the MSCC are caused by an epidural compression from a tumour or a bony fragment from the collapsed vertebra affected by the metastasis. The most common of the tumours that metastasize to the spinal cord are breast and lung cancer, followed by lymphoma, myeloma, prostate cancer and sarcoma. Conclusions. The most common symptom of MSCC is pain, followed by muscular weakness and autonomic dysfunction. MRI provides the best information regarding MSCC, so all patientsshould have a MRI as soon as possible. If the MRI is contraindicated, patients should have the CT scan done. All patients with newly diagnosed MSCC should receive corticosteroids immediately, even before the definitive diagnosis is made. Other treatment options are surgery with postoperative radiotherapy, radiotherapy only, specific medical therapies according to the tumour type and symptomatic therapy, (mainly opiates). The decision of treatment modalities should be made according to the NOMS (neurological, oncological, mechanical and systemic) principles. In spite of the advances, the treatment is still palliative and many patients with MSCC have a poor prognosis and a short survival.
Objavljeno v DiRROS: 07.03.2024; Ogledov: 74; Prenosov: 17
.pdf Celotno besedilo (152,89 KB)

2.
Kidney cancer
Mirjana Rajer, 2007, strokovni članek

Objavljeno v DiRROS: 20.02.2024; Ogledov: 94; Prenosov: 24
.pdf Celotno besedilo (213,38 KB)

3.
Basic Clinical Radiobiology Course Ljubljana (Slovenia), 21.-25. May 2006 : view from local participant
Mirjana Rajer, 2007, drugi sestavni deli

Objavljeno v DiRROS: 20.02.2024; Ogledov: 90; Prenosov: 26
.pdf Celotno besedilo (66,97 KB)

4.
Locoregional control and survival after breast conserving therapy
Mirjana Rajer, Elga Majdič, 2006, izvirni znanstveni članek

Objavljeno v DiRROS: 15.02.2024; Ogledov: 82; Prenosov: 24
.pdf Celotno besedilo (631,72 KB)

5.
Quantitative analysis of fine needle aspiration biopsy samples
Mirjana Rajer, Marko Kmet, 2005, izvirni znanstveni članek

Povzetek: The fine needle aspiration biopsy (FNAB) is one of the methods used in tumour evaluation. Since a certain number of tumour cells are needed for a complete diagnostic algorithem, we wanted to test how many cells remain in the needle and syringe after routine stains have been made and which factors influence this number. The remaining cells are used in ancillary diagnostic procedures. Material and methods. One hundred fifty two FNAB samples of tumours of the breast, thyroid and lymph nodes were included in our study. We counted the cells which were left in the needle and the syringe after the standard smears had been made. Buerker-Tuerks chamber was used for this purpose. Results. The number of cells depended on the organ from which the cells had been aspirated,on the type of tumour and, in the case of breast cancer, also on thelevel of experience of the FNAB performer. The percentage of samples with too few cells for all modern diagnostic methods (<5x105) is lowest in FNAB of lymph nodes (4.9%), followed by breast (16.7%) and thyroid (18%). Conclusions.We concluded that FNAB in the majority of cases grants a sufficient number of cells for the standard microscopic evaluation and also ancillary diagnostic procedures.
Objavljeno v DiRROS: 14.02.2024; Ogledov: 100; Prenosov: 23
.pdf Celotno besedilo (104,56 KB)

6.
Mnenje za spremljanje bolnikov po preboleli covidni pljučnici
Matjaž Turel, Natalija Edelbaher, Matjaž Fležar, Matevž Harlander, Peter Kecelj, Izidor Kern, Majda Kočar, Peter Kopač, Mitja Košnik, Robert Marčun, Igor Požek, Mirjana Rajer, Irena Šarc, Jurij Šorli, Dušanka Vidovič, Katarina Osolnik, 2021, izvirni znanstveni članek

Povzetek: Pljučnica je najpogostejši vzrok za težji potek okužbe z virusom SARS-CoV-2 in s hospitalizacijo. Potek covidne pljučnice je lahko različen; infiltrati, vidni na rentgenski sliki, se lahko resorbirajo spontano, včasih pa je potrebno zdravljenje s sistem-skimi glukokortikoidi. Ob odpustu iz bolnišnice zdravljenje običajno še ni končano, zato je Združenje pulmologov Slovenije v želji po enotnem obravnavanju bolnikov s covidno pljučnico izdelalo mnenje za obravnavo in sledenje bolnikov po od-pustu iz bolnišnice. Zavedamo se, da ob novi bolezni ne gre za dokončno priporočilo, saj bodo nova spoznanja o covidni pljučnici zanesljivo zahtevala obnavljanje priporočil.
Ključne besede: covid-19, mnenja, pljučnica, pulmologija, sistemski glukokortikoidi, covidna pljučnica
Objavljeno v DiRROS: 15.12.2021; Ogledov: 1059; Prenosov: 188
URL Povezava na datoteko

7.
Epidemiologija in etiologija pljučnega raka
Mirjana Rajer, 2015, objavljeni strokovni prispevek na konferenci (vabljeno predavanje)

Ključne besede: pljučni rak, epidemiologija, etiologija
Objavljeno v DiRROS: 08.05.2020; Ogledov: 1485; Prenosov: 429
.pdf Celotno besedilo (323,91 KB)

8.
Prvi šoli pljučnega raka na pot
Mirjana Rajer, Viljem Kovač, 2015, predgovor, uvodnik, spremna beseda

Ključne besede: pljučni rak, izobraževanje, zborniki
Objavljeno v DiRROS: 08.05.2020; Ogledov: 1297; Prenosov: 375
.pdf Celotno besedilo (133,65 KB)

9.
Ali res obstaja alternativno zdravljenje pljučnega raka
Mirjana Rajer, 2016, objavljeni strokovni prispevek na konferenci (vabljeno predavanje)

Ključne besede: rak pljuč, zdravljenje, alternativno zdravljenje
Objavljeno v DiRROS: 08.05.2020; Ogledov: 1746; Prenosov: 453
.pdf Celotno besedilo (90,87 KB)

10.
Zbornik
2015, zbornik strokovnih ali nerecenziranih znanstvenih prispevkov na konferenci

Objavljeno v DiRROS: 23.04.2020; Ogledov: 1381; Prenosov: 427
.pdf Celotno besedilo (4,90 MB)

Iskanje izvedeno v 0.24 sek.
Na vrh